JPWO2019152627A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019152627A5
JPWO2019152627A5 JP2020541528A JP2020541528A JPWO2019152627A5 JP WO2019152627 A5 JPWO2019152627 A5 JP WO2019152627A5 JP 2020541528 A JP2020541528 A JP 2020541528A JP 2020541528 A JP2020541528 A JP 2020541528A JP WO2019152627 A5 JPWO2019152627 A5 JP WO2019152627A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
subject
composition according
dapansutrile
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020541528A
Other languages
English (en)
Japanese (ja)
Other versions
JP7290872B2 (ja
JP2021512086A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016012 external-priority patent/WO2019152627A1/en
Publication of JP2021512086A publication Critical patent/JP2021512086A/ja
Publication of JPWO2019152627A5 publication Critical patent/JPWO2019152627A5/ja
Application granted granted Critical
Publication of JP7290872B2 publication Critical patent/JP7290872B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020541528A 2018-01-31 2019-01-31 アルツハイマー病の予防又は治療方法 Active JP7290872B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862624637P 2018-01-31 2018-01-31
US62/624,637 2018-01-31
PCT/US2019/016012 WO2019152627A1 (en) 2018-01-31 2019-01-31 Method for preventing or treating alzheimer's disease

Publications (3)

Publication Number Publication Date
JP2021512086A JP2021512086A (ja) 2021-05-13
JPWO2019152627A5 true JPWO2019152627A5 (xx) 2022-01-31
JP7290872B2 JP7290872B2 (ja) 2023-06-14

Family

ID=67478566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020541528A Active JP7290872B2 (ja) 2018-01-31 2019-01-31 アルツハイマー病の予防又は治療方法

Country Status (7)

Country Link
US (1) US11517554B2 (xx)
EP (1) EP3746057B1 (xx)
JP (1) JP7290872B2 (xx)
CN (1) CN111670032A (xx)
CA (1) CA3087865A1 (xx)
MX (1) MX2020007941A (xx)
WO (1) WO2019152627A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3094307A1 (en) * 2018-03-21 2019-09-26 Olatec Therapeutics Llc Methods for treating melanoma
AU2020366300A1 (en) * 2019-10-14 2022-06-02 Olatec Therapeutics Llc Methods for treating breast cancer
CN117897151A (zh) * 2021-08-19 2024-04-16 欧拉泰克治疗公司 用于治疗帕金森氏病的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2651407B1 (en) * 2010-12-15 2016-12-21 Olatec Industries LLC 3-methanesulfonylpropionitrile for treating inflammation and pain
CN104869993B (zh) * 2012-10-25 2019-01-15 通用医疗公司 治疗阿尔茨海默病及相关疾病的组合疗法
CA2911547A1 (en) * 2013-05-31 2014-12-04 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to treat alzheimer's disease
WO2015165961A1 (en) * 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
EP4215527A1 (en) * 2015-02-26 2023-07-26 University Of Kentucky Research Foundation Compositions and methods for treating retinal degradation

Similar Documents

Publication Publication Date Title
AU2009227629B2 (en) Dosing regimen for a selective S1P1 receptor agonist
ES2372421T3 (es) Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopáusicos.
TWI250016B (en) Use of pramipexole for the treatment of addictive disorders
JPS6143112A (ja) 精神性欲機能障害治療剤
JP3756193B2 (ja) 睡眠時呼吸障害を治療および診断する方法、並びにこの方法を実施する手段
JP2005515966A5 (xx)
BR112020008128A2 (pt) comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos
JP2021502392A5 (xx)
KR970061244A (ko) 치매 치료용 약학 조성물
JPH0761923A (ja) アルツハイマー病治療剤
JPWO2019152627A5 (xx)
EP1944030B1 (en) Agent for treatment of schizophrenia
DE60125062T2 (de) Quetiapin zur Behandlung der Dyskinesie in nicht-psychotischen Patienten
RU2002129298A (ru) Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера
JPWO2021211489A5 (xx)
CN1853619A (zh) 阿戈美拉汀在获得用于治疗双相性精神障碍的药物中的用途
EP0402208B1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
JP6420923B1 (ja) 医薬
JP2009501205A (ja) 精神病治療用組成物
JPH07507280A (ja) （−）−メトリフォネート含有薬剤
CA2368352A1 (en) Method for treating neurodegeneration
WO2023066330A1 (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
CN106822158B (zh) 红景天苷用于防治阻塞性睡眠呼吸暂停诱导型高血压
WO2022241724A1 (zh) TGFβ通路抑制剂在制备预防或治疗血脑屏障损害的药物或保健品中的应用
CN114984034A (zh) 一种寡糖类化合物的应用